Nov 24, 2025 · What is pembrolizumab? Pembrolizumab (Keytruda) is an immunotherapy used to treat cancers, including types of non-small cell lung cancer (NSCLC), breast cancer, melanoma, head and …

Pembrolizumab works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system.

Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. [12][14] It …

Pembrolizumab is a medication used in the management and treatment of various oncologic conditions. It is in the cancer immunotherapy class of drugs.

Pembrolizumab is a type of immunotherapy. It is a treatment for a number of different types of cancer such as melanoma. Find out about how you have it, possible side effects and other important …

Nov 1, 2025 · Pembrolizumab injection is used to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) classical Hodgkin lymphoma (cHL) in adults.

Learn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. Visit the patient website.

What is pembrolizumab (Keytruda®)? Pembrolizumab is a type of immunotherapy drug called a checkpoint inhibitor. Pembrolizumab (Keytruda ®) is used to treat many types of cancer. It is best to …

Mar 23, 2025 · Pembrolizumab works as a form of immunotherapy by binding to the "programmed death receptor" (PD1) found on T-cells to stimulate the immune system to find and kill cancer cells. …

Dec 18, 2024 · Keytruda (pembrolizumab) is commonly used to treat certain types of the following types of cancers. Keytruda may also be used for other conditions as determined by your healthcare …